Description
Why It’s Done:
• To diagnose myeloproliferative disorders: The JAK2 V617F mutation is commonly found in individuals with conditions like polycythemia vera, essential thrombocythemia, and primary myelofibrosis—all of which are disorders where the bone marrow produces too many blood cells.
• To evaluate abnormal blood counts: The test helps in the assessment of unexplained elevated red blood cell, white blood cell, or platelet counts, which may indicate a myeloproliferative disorder.
• To confirm a diagnosis: The test is often performed when there is a suspicion of JAK2-related hematologic conditions, helping to confirm or rule out the presence of the mutation.
• To monitor treatment: For patients diagnosed with myeloproliferative diseases, this test can be used to monitor disease progression and assess response to therapies targeting the JAK2 mutation.
Preparation:
• Fasting is not required for this test.
• A blood sample is taken, usually from a vein in your arm.
• Inform your healthcare provider about any medications or treatments you are undergoing, especially if you are taking chemotherapy or immunosuppressive drugs, as these can affect blood cell production and may influence the results.
• No special preparations are needed beyond following the healthcare provider’s instructions.
